Although we have collected data from two different cohorts of patients (gastrointestinal and lung cancer), the study of the GDF-15 serum levels in additional different cancer type and stages might reveal whether anorexia is present/absent according to the GFD-15 serum levels or to the type/stage of the underlying cancer disease. This evidence concerns the gene GDF15 and cancer.